Response to Letter Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation"

Affiliations

• ¹ Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
• ² Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.
• ³ First Department of Medicine, University Medical Center Mannheim, Mannheim, Germany.
• ⁴ Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands.
• ⁵ Department for Bioinformatics and Functional Genomics, Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Institute for Pharmacy and Molecular Biotechnology (IPMB) and BioQuant, Heidelberg University, Heidelberg, Germany.
• ⁶ Department of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
• ⁷ Department of Cardiology, Internal Medicine III, Goethe University, Frankfurt, Germany.
• ⁸ Department of Cardiology, St. Josefs-Hospital, Wiesbaden, Germany.
• ⁹ Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, Szeged, Hungary.
• ¹⁰ Department of Cardiology, University of Basel Children's Hospital, Basel, Switzerland.